Xie Lin, Liao Yedan, Shen Lida, Hu Fengdi, Yu Sunlin, Zhou Yonghong, Zhang Ya, Yang Yihao, Li Dongqi, Ren Minyan, Yuan Zhongqin, Yang Zuozhang
Bone and Soft Tissue Tumors Research Center of Yunnan Province, Department of Orthopaedics, The Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China.
Department of Medical Oncology, The Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China.
Oncotarget. 2017 Jun 27;8(26):42525-42536. doi: 10.18632/oncotarget.17208.
Small cell osteosarcoma (SCO) is a rare subtype of osteosarcoma characterized by highly aggressive progression and a poor prognosis. The miRNA and mRNA expression profiles of peripheral blood mononuclear cells (PBMCs) were obtained in 3 patients with SCO and 10 healthy individuals using high-throughput RNA-sequencing. We identified 37 dysregulated miRNAs and 1636 dysregulated mRNAs in patients with SCO compared to the healthy controls. Specifically, the 37 dysregulated miRNAs consisted of 27 up-regulated miRNAs and 10 down-regulated miRNAs; the 1636 dysregulated mRNAs consisted of 555 up-regulated mRNAs and 1081 down-regulated mRNAs. The target-genes of miRNAs were predicted, and 1334 negative correlations between miRNAs and mRNAs were used to construct an miRNA-mRNA regulatory network. Dysregulated genes were significantly enriched in pathways related to cancer, mTOR signaling and cell cycle signaling. Specifically, hsa-miR-26b-5p, hsa-miR-221-3p and hsa-miR-125b-2-3p were significantly dysregulated miRNAs and exhibited a high degree of connectivity with target genes. Overall, the expression of dysregulated genes in tumor tissues and peripheral blood samples of patients with SCO measured by quantitative real-time polymerase chain reaction corroborated with our bioinformatics analyses based on the expression profiles of PBMCs from patients with SCO. Thus, hsa-miR-26b-5p, hsa-miR-221-3p and hsa-miR-125b-2-3p may be involved in SCO tumorigenesis.
小细胞骨肉瘤(SCO)是骨肉瘤的一种罕见亚型,其特征为进展高度侵袭性且预后较差。使用高通量RNA测序技术,在3例SCO患者和10名健康个体中获取了外周血单核细胞(PBMC)的miRNA和mRNA表达谱。与健康对照相比,我们在SCO患者中鉴定出37个失调的miRNA和1636个失调的mRNA。具体而言,37个失调的miRNA包括27个上调的miRNA和10个下调的miRNA;1636个失调的mRNA包括555个上调的mRNA和1081个下调的mRNA。预测了miRNA的靶基因,并利用1334个miRNA与mRNA之间的负相关构建了一个miRNA-mRNA调控网络。失调基因在与癌症、mTOR信号传导和细胞周期信号传导相关的通路中显著富集。具体来说,hsa-miR-26b-5p、hsa-miR-221-3p和hsa-miR-125b-2-3p是显著失调的miRNA,并且与靶基因表现出高度的连接性。总体而言,通过定量实时聚合酶链反应测量的SCO患者肿瘤组织和外周血样本中失调基因的表达与我们基于SCO患者PBMC表达谱的生物信息学分析结果一致。因此,hsa-miR-26b-5p、hsa-miR-221-3p和hsa-miR-125b-2-3p可能参与了SCO的肿瘤发生。